Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by John T. Vetto
Chemoprevention Agents for Melanoma: A Path Forward Into Phase 3 Clinical Trials
Cancer
Cancer Research
Oncology
Invited Brief Commentary: Sentinel Lymph Node Status Is a Main Prognostic Parameter Needful for the Correct Staging of Patients With Melanoma Thicker Than 4 Mm: Single Institutional Experience and Literature Meta-Analysis
Journal of Investigative Surgery
Surgery
Related publications
Erratum: Jeter JM, Bowles TL, Curiel‐Lewandrowski C, Et Al. Chemoprevention Agents for Melanoma: A Path Forward Into Phase 3 Clinical Trials. Cancer . 2019:125:18‐44.
Cancer
Cancer Research
Oncology
Clinical Trials on Sarcopenia: Methodological Issues Regarding Phase 3 Trials
Clinics in Geriatric Medicine
Gerontology
Geriatrics
Criteria for Implementation of Large and Multiagent Clinical Chemoprevention Trials
Journal of Cellular Biochemistry
Biochemistry
Cell Biology
Molecular Biology
Ethics in Clinical Trials : Ethical Standards in Phase 1 Trials of Neuroprotective Agents for Stroke Therapy
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Chemoprevention of Melanoma
Current Challenges in Personalized Cancer Medicine
Clinical Trials in Idiopathic Pulmonary Fibrosis: A Framework for Moving Forward
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials
Current Diabetes Reviews
Endocrinology
Metabolism
Diabetes
A Dynamic Stopping Rule for Phase I Clinical Trials
Biometrical Letters
Phase 2 and 3 Clinical Trials in Pulmonary Arterial Hypertension
Advances in Pulmonary Hypertension
